Xiuqi Wei
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
- Oncology 6
- COVID-19 and healthcare impacts 3
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Wenbin Tan (6 shared papers)Jingyu Su (5 shared papers)Xiaoling Cao (5 shared papers)Huimin Wan (3 shared papers)Hui Wang (4 shared papers)Wenjuan Zeng (1 shared paper)Kunyu Yang (2 shared papers)Hui Wang (2 shared papers)
- Journals
- BMC Gastroenterology (2 papers)Frontiers in Oncology (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Technology in Cancer Research & Treatment (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiuqi Wei
13 papers receiving 420 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 259
- Neurology 90
- Epidemiology 123
- Cancer Research 53
- Hepatology 23
Countries citing papers authored by Xiuqi Wei
This map shows the geographic impact of Xiuqi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuqi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuqi Wei more than expected).
Fields of papers citing papers by Xiuqi Wei
This network shows the impact of papers produced by Xiuqi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuqi Wei. The network helps show where Xiuqi Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiuqi Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 241 | |
| 2 | 2020 | 55 | |
| 3 | 2019 | 35 | |
| 4 | 2021 | 27 | |
| 5 | 2019 | 19 | |
| 6 | 2018 | 16 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 6 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 3 | |
| 13 | 2024 | 1 |
About Xiuqi Wei
Xiuqi Wei is a scholar working on Oncology, Infectious Diseases, Surgery, Molecular Biology and Epidemiology, having authored 13 papers that have together received 431 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 and healthcare impacts (3 papers), Cancer-related molecular mechanisms research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), MicroRNA in disease regulation (2 papers), Extracellular vesicles in disease (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Infectious Diseases (259 citations), Neurology (90 citations), Epidemiology (123 citations), Cancer Research (53 citations) and Hepatology (23 citations). Xiuqi Wei has collaborated with scholars based in China and United States. Frequent co-authors include Wenbin Tan, Jingyu Su, Xiaoling Cao, Huimin Wan, Hui Wang, Wenjuan Zeng, Kunyu Yang, Hui Wang, Hui Wang and Bian Wu. Their work appears in journals such as BMC Gastroenterology, Frontiers in Oncology, Alimentary Pharmacology & Therapeutics, Technology in Cancer Research & Treatment and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.